Home » Clinical Trials » Search Clinical Trials
Parent Therapeutic Areas: Neurology
Alzheimer's Disease
ABT-089, an investigational drug for the treatment of mild to moderate Alzheimer's Disease
Phase II - ACC-001 Vaccine treatment for mild to moderate Alzheimer's Disease, trial study
Phase III - Avandia treatment for Alzheimer's disease as a means to reduce inflammation and increase sugar uptake in the brain.
Phase IV - Alzheimer's Disease Once-a-day Patch Medication, Trial Study
Alzheimer's Disease Clinical Research Study
Alzheimer's Disease Clinical Research Study
Mild to Moderate Alzheimer's disease
Mild to Moderate Alzheimer's disease
Study of an investigational medication for the treatment of Alzheimer's Disease
Alzheimer’s Disease Research Study Opportunity Currently Available
Alzheimer’s Research Study
Global early-stage research study to evaluate an investigational medication for early-stage Alzheimer’s disease
Study of an investigational medication for the treatment of Alzheimer's Disease
Alzheimer's Disease - Memory Loss
Alzheimer's Disease - Memory Loss
Study of an investigational medication for the treatment of Alzheimer's Disease
Study of an investigational medication for the treatment of Alzheimer's Disease
Alzheimers? Be a Part of Research.
JOIN THE FIGHT AGAINST ALZHEIMER’S DISEASE
Research study of a currently marketed medication for Alzheimer’s Disease.
Research study of an investigational medication for those who are at risk to develop Alzheimer’s Disease.
Evaluation of a investigational oral medication for patients with Alzheimer’s Disease.
New Investigational Medication for Alzheimer’s disease
New Study Aimed to Slow the Progression of Alzheimer's Disease
New Vaccine for Individuals with Mild Alzheimer’s disease
Alzheimer’s Disease
Alzheimer’s? Questions about treatment options?
Do you know or care for someone currently taking Aricept® for alzheimer's?
If you or someone you know is experiencing memory loss, they may qualify for a clinical research study currently being conducted by Radiant Research.
Research for Alzheimer's Disease
The Effectiveness And Safety Of Donepezil Hydrochloride (E2020) In Subjects With Mild To Severe Alzheimer's Disease Residing In An Assisted Living Facility
A Randomized, Double-Blind, Placebo-Controlled, Parallel, 24-Week, Adaptive Design Phase 2 Study of Three Different Doses of an Alpha-7 Nicotinic Acetylcholine Receptor Agonist (EVP-6124) or Placebo in Subjects with Mild to Moderate Probable Alzheimer’s Disease.
Alzheimer's Disease
Alzheimer's study.
Alzheimer's Disease
Alzheimer's Disease
Alzheimer's study
Alzheimer's Disease
Alzheimer''s Disease
Phase 3 trial evaluating Treatment with intravenous Bapineuzumab vs. Placebo for Alzheimer's disease
Randomized, Double blind, placebo controlled, parallel group, efficacy and safety trial of bapineuzumab in patients with mild to moderate Alzheimer's disease
Alzheimer's Disease, Moderate
Alzheimer's Disease, Moderate to Severe
The Effectiveness And Safety Of Donepezil Hydrochloride (E2020) In Subjects With Mild To Severe Alzheimer's Disease Residing In An Assisted Living Facility
A Longitudinal Study of Familial, Early-onset Alzheimer’s Disease
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Efficacy and Safety Trial of Bapineuzumab (AAB-001, ELN115727) in Subjects with Mild to Moderate Alzheimer’s Disease
CONCERT: A Phase 3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Twelve-Month Safety and Efficacy Study Evaluating Dimebon in Patients with Mild-to-Moderate Alzheimer’s Disease on Donepezil
CONCERT: A Phase 3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Twelve-Month Safety and Efficacy Study Evaluating Dimebon in Patients with Mild-to- Moderate Alzheimer’s Disease on Donepezil
Implications of Amyloid Deposition in Clinically Normal Older Individuals
Research Study for Identifying Early Biomarkers of Alzheimer's Disease
Do You Or Someone You Know Have Alzheimer's Disease?
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Efficacy and Safety Trial of Bapineuzumab in Subjects With Mild to Moderate Alzheimer Disease Who Are Apolipoprotein E e4 Carriers
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy and Safety Trial of Bapineuzumab (AAB-001, ELN115727) In Patients With Mild to Moderate Alzheimer's Disease Who Are Apolipoprotein E4 Non- Carriers
Effect of LY450139 a y-Secretase Inhibitor, on the Progression of Alzheimer's Disease as Compared With Placebo
Effect of Passive Immunization on the Progression of Alzheimer's Disease: LY2062430 Versus Placebo
Are you or someone you know between the ages of 50 and 89 years of age with a diagnosis of mild to moderate Alzheimer's Disease?
Alzheimer's disease study for mild to moderate AD.
Parker Jewish Institute for Health Care & Rehabilitation Seeks Study Volunteers with Alzheimer's Disease
Have you or someone you love been diagnosed with Alzheimer’s Disease?
Is Alzheimer’s Disease affecting your loved one?
ALZHEIMER'S DISEASE: Don't let those memories fade…
Alzheimer's Disease
Memory Loss Research Study
Research Study for Agitation and Aggression Associated with Alzheimer’s Disease
BEHAVIOR & PERSONALITY CHANGES IN ALZHEIMER’S DISEASE
SUFFERING FROM ALZHEIMER’S DISEASE?
The Effectiveness And Safety Of Donepezil Hydrochloride (E2020) In Subjects With Mild To Severe Alzheimer's Disease Residing In An Assisted Living Facility
Alzheimer’s Research Study
Alzheimer's Disease
Clinical Research Study for Alzheimer’s Disease
Have you or someone you love been diagnosed with Alzheimer's Disease?
Moderate to Severe Alzheimer’s
A clinical research trial evaluating an investigational drug for people with Alzheimer’s.
